Patent ID: 8552055
Filing Date: 2013-10-08
Classification: A23K,A23L,A23V,A61K,A61P

Abstract:
1. A method of enhancing neurotransmission wherein the neurotransmission effect is selected from the group consisting of: an antidepressant, mood/vitality improver, stress reliever, condition improver, reducer of anxiety, reducer of obsessive-compulsive behaviour, relaxant, sleep improver and/or insomnia alleviator comprising: administering a dietary or pharmaceutical composition containing 0.001 mg per kg body weight to about 20 mg per kg body weight per day of a compound selected from the group consisting of: carnosic acid 12-methyl ether, 7-oxocallitrisic acid, totarol, 16-hydroxytotarol, totarol-19-carboxylic acid methyl ester, 20-deoxo-carnosol, 7-methyfrosmanol, sageone, 8,11,13-abietatriene-11,12,20-triol, royleanonic acid and ferruginol to a healthy person in need thereof; or 0.001 mg per kg bodyweight to 1000 mg per kg bodyweight per day to an animal excluding humans in in need thereof and observing an enhanced neurotransmission effect.